Quercetin
- Generic Name
- Quercetin
- Drug Type
- Small Molecule
- Chemical Formula
- C15H10O7
- CAS Number
- 117-39-5
- Unique Ingredient Identifier
- 9IKM0I5T1E
- Background
Quercetin is a flavonol widely distributed in plants. It is an antioxidant, like many other phenolic heterocyclic compounds. Glycosylated forms include RUTIN and quercetrin.
Quercetin In The Treatment Of SARS-COV 2
- Conditions
- SARS (Severe Acute Respiratory Syndrome)
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-04-21
- Last Posted Date
- 2023-07-06
- Lead Sponsor
- Hôpital Universitaire Sahloul
- Target Recruit Count
- 200
- Registration Number
- NCT04853199
- Locations
- 🇹🇳
Riadh Boukef, Sahloul, Sousse, Tunisia
🇹🇳HU Sahloul, sousse, Tunisia, Sousse, Itinéraire Ceinture Cité Sahloul, Tunisia
The Effectiveness of Phytotherapy in SARS-COV2(COVID-19)
- Conditions
- a Randomized Double-blind StudySevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)PHYTOTHERAPIE
- Interventions
- First Posted Date
- 2021-04-20
- Last Posted Date
- 2023-01-04
- Lead Sponsor
- Hôpital Universitaire Sahloul
- Target Recruit Count
- 80
- Registration Number
- NCT04851821
- Locations
- 🇹🇳
Riadh Boukef, Sahloul, Sousse, Tunisia
ALSENLITE: Senolytics for Alzheimer's Disease
- Conditions
- Alzheimer DiseaseMild Cognitive Impairment
- Interventions
- First Posted Date
- 2021-03-05
- Last Posted Date
- 2025-01-17
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 20
- Registration Number
- NCT04785300
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
The Study of Quadruple Therapy Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected With COVID-19
- Conditions
- Covid-19
- Interventions
- First Posted Date
- 2020-07-13
- Last Posted Date
- 2020-07-13
- Lead Sponsor
- Ministry of Health, Saudi Arabia
- Target Recruit Count
- 60
- Registration Number
- NCT04468139
- Locations
- 🇸🇦
Ministry of health.First health cluster ,Riaydh, Riyadh, Saudi Arabia
Targeting Cellular Senescence With Senolytics to Improve Skeletal Health in Older Humans
- First Posted Date
- 2020-03-18
- Last Posted Date
- 2024-07-22
- Lead Sponsor
- Sundeep Khosla, M.D.
- Target Recruit Count
- 74
- Registration Number
- NCT04313634
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Quercetin for Cardio-Skeletal Muscle Health and Estrogen Deficiency
- Conditions
- Menopause Related Conditions
- Interventions
- Drug: Placebo oral soft chew
- First Posted Date
- 2020-02-06
- Last Posted Date
- 2022-10-10
- Lead Sponsor
- Wake Forest University Health Sciences
- Registration Number
- NCT04258410
Biological Effects of Quercetin in COPD
- First Posted Date
- 2019-06-18
- Last Posted Date
- 2023-08-16
- Lead Sponsor
- Temple University
- Target Recruit Count
- 29
- Registration Number
- NCT03989271
- Locations
- 🇺🇸
Nathaniel Marchetti, Philadelphia, Pennsylvania, United States
Sirtuin-1 and Advanced Glycation End-products in Postmenopausal Women With Coronary Disease
- First Posted Date
- 2019-05-09
- Last Posted Date
- 2019-10-04
- Lead Sponsor
- InCor Heart Institute
- Target Recruit Count
- 60
- Registration Number
- NCT03943459
- Locations
- 🇧🇷
INCOR - Heart Institute, São Paulo, Brazil
Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia
- Conditions
- Fanconi AnemiaSquamous Cell Carcinoma
- Interventions
- First Posted Date
- 2018-03-26
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Children's Hospital Medical Center, Cincinnati
- Target Recruit Count
- 48
- Registration Number
- NCT03476330
- Locations
- 🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Trial of Quercetin in the Treatment and Prevention of Chemotherapy-induced Neuropathic Pain in Cancer Patients
- Conditions
- Chemotherapy Induced Neuropathic PainPolyneuropathies and Other Disorders of the Peripheral Nervous System
- Interventions
- Behavioral: Questionnaires
- First Posted Date
- 2016-12-12
- Last Posted Date
- 2018-04-18
- Lead Sponsor
- M.D. Anderson Cancer Center
- Registration Number
- NCT02989129
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.